We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi, Regeneron Sue Amgen to Prevent Patent Dispute over Eczema Drug Dupixent
Sanofi, Regeneron Sue Amgen to Prevent Patent Dispute over Eczema Drug Dupixent
Sanofi and Regeneron filed a complaint seeking a declaratory judgment that their eczema drug Dupixent, which is pending an FDA approval, does not infringe an Amgen patent on an unsuccessful asthma candidate.